{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:28:45Z","timestamp":1762079325720},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1475-2875-10-376","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T07:31:33Z","timestamp":1324366293000},"source":"Crossref","is-referenced-by-count":31,"title":["Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America"],"prefix":"10.1186","volume":"10","author":[{"given":"Irina T","family":"Jovel","sequence":"first","affiliation":[]},{"given":"Rosa E","family":"Mej\u00eda","sequence":"additional","affiliation":[]},{"given":"Engels","family":"Banegas","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Piedade","sequence":"additional","affiliation":[]},{"given":"Jackeline","family":"Alger","sequence":"additional","affiliation":[]},{"given":"Gustavo","family":"Fontecha","sequence":"additional","affiliation":[]},{"given":"Pedro E","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Maria I","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Irma G","family":"Enamorado","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Bjorkman","sequence":"additional","affiliation":[]},{"given":"Johan","family":"Ursing","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,19]]},"reference":[{"key":"1952_CR1","volume-title":"Malaria Guidelines in Honduras","author":"National Malaria Programme","year":"2010","unstructured":"National Malaria Programme: Malaria Guidelines in Honduras. 2010, Tegucigalpa: Honduras Ministry of Health, First","edition":"First"},{"key":"1952_CR2","volume-title":"Malaria Situation in Honduras 2010","author":"National Malaria Programme","year":"2011","unstructured":"National Malaria Programme: Malaria Situation in Honduras 2010. 2011, Tegucigalpa: Ministry of Health"},{"key":"1952_CR3","volume-title":"Global Report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva","author":"WHO","year":"2010","unstructured":"WHO: Global Report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva. 2010"},{"key":"1952_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. NEJM. 2001, 344: 257-263.","journal-title":"NEJM"},{"key":"1952_CR5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4269\/ajtmh.2007.76.844","volume":"76","author":"J Ursing","year":"2007","unstructured":"Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP: Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am J Trop Med Hyg. 2007, 76: 844-848.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P: A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009, 8: 89-","journal-title":"Malar J"},{"key":"1952_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1086\/320195","volume":"183","author":"HA Babiker","year":"2001","unstructured":"Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D: High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis. 2001, 183: 1535-1538.","journal-title":"J Infect Dis"},{"key":"1952_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/427997","volume":"191","author":"C Sisowath","year":"2005","unstructured":"Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, Gil JP: In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis. 2005, 191: 1014-1017.","journal-title":"J Infect Dis"},{"key":"1952_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","volume":"12","author":"C Sisowath","year":"2007","unstructured":"Sisowath C, Ferreira PE, Bustamante LY, Dahlstrom S, Martensson A, Bjorkman A, Krishna S, Gil JP: The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health. 2007, 12: 736-742.","journal-title":"Trop Med Int Health"},{"key":"1952_CR10","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AAC.00638-09","volume":"53","author":"L Mwai","year":"2009","unstructured":"Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, Bull P, Marsh K, Borrmann S, Nzila A: In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009, 53: 5069-5073.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR11","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","volume":"43","author":"RN Price","year":"1999","unstructured":"Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S: The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother. 1999, 43: 2943-2949.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S: Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004, 364: 438-447.","journal-title":"Lancet"},{"key":"1952_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1086\/503423","volume":"42","author":"RN Price","year":"2006","unstructured":"Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F: Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis. 2006, 42: 1570-1577.","journal-title":"Clin Infect Dis"},{"key":"1952_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.2000.62.271","volume":"62","author":"LK Basco","year":"2000","unstructured":"Basco LK, Ringwald P: Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg. 2000, 62: 271-276.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR15","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1111\/j.1742-4658.2007.05999.x","volume":"274","author":"JE Hyde","year":"2007","unstructured":"Hyde JE: Drug-resistant malaria - an insight. FEBS J. 2007, 274: 4688-4698.","journal-title":"FEBS J"},{"key":"1952_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002, 185: 380-388.","journal-title":"J Infect Dis"},{"key":"1952_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/587845","volume":"197","author":"C Lynch","year":"2008","unstructured":"Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C: Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008, 197: 1598-1604.","journal-title":"J Infect Dis"},{"key":"1952_CR18","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/AAC.01459-07","volume":"52","author":"M Imwong","year":"2008","unstructured":"Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ: Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother. 2008, 52: 2657-2659.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR19","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1371\/journal.pone.0001089","volume":"2","author":"R Suwanarusk","year":"2007","unstructured":"Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN: Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One. 2007, 2: e1089-","journal-title":"PLoS One"},{"key":"1952_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/592451","volume":"198","author":"R Suwanarusk","year":"2008","unstructured":"Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN: Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis. 2008, 198: 1558-1564.","journal-title":"J Infect Dis"},{"key":"1952_CR21","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1128\/AAC.46.12.3947-3953.2002","volume":"46","author":"E Tjitra","year":"2002","unstructured":"Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM: Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob Agents Chemother. 2002, 46: 3947-3953.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR22","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/AAC.45.11.3122-3127.2001","volume":"45","author":"M Imwong","year":"2001","unstructured":"Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Snounou G: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother. 2001, 45: 3122-3127.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1086\/381397","volume":"189","author":"MD Hastings","year":"2004","unstructured":"Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bangs MJ, Sibley CH, Baird JK: Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J Infect Dis. 2004, 189: 744-750.","journal-title":"J Infect Dis"},{"key":"1952_CR24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.2006.75.617","volume":"75","author":"A Auliff","year":"2006","unstructured":"Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q: Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg. 2006, 75: 617-621.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR25","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.0501747102","volume":"102","author":"P Kongsaeree","year":"2005","unstructured":"Kongsaeree P, Khongsuk P, Leartsakulpanich U, Chitnumsub P, Tarnchompoo B, Walkinshaw MD, Yuthavong Y: Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. Proc Natl Acad Sci USA. 2005, 102: 13046-13051.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.meegid.2008.02.002","volume":"8","author":"S Dahlstrom","year":"2008","unstructured":"Dahlstrom S, Veiga MI, Ferreira P, Martensson A, Kaneko A, Andersson B, Bjorkman A, Gil JP: Diversity of the sarco\/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol. 2008, 8: 340-345.","journal-title":"Infect Genet Evol"},{"key":"1952_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mcp.2005.10.003","volume":"20","author":"MI Veiga","year":"2006","unstructured":"Veiga MI, Ferreira PE, Bjorkman A, Gil JP: Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. Mol Cell Probes. 2006, 20: 100-104.","journal-title":"Mol Cell Probes"},{"key":"1952_CR28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4269\/ajtmh.2007.77.1034","volume":"77","author":"DF Echeverry","year":"2007","unstructured":"Echeverry DF, Holmgren G, Murillo C, Higuita JC, Bjorkman A, Gil JP, Osorio L: Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am J Trop Med Hyg. 2007, 77: 1034-1038.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2875-7-72","volume":"7","author":"VN Hawkins","year":"2008","unstructured":"Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH: Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase. Malar J. 2008, 7: 72-","journal-title":"Malar J"},{"key":"1952_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actatropica.2010.08.011","volume":"117","author":"F Lu","year":"2011","unstructured":"Lu F, Lim CS, Nam DH, Kim K, Lin K, Kim TS, Lee HW, Chen JH, Wang Y, Sattabongkot J, Han ET: Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries. Acta Trop. 2011, 117: 69-75.","journal-title":"Acta Trop"},{"key":"1952_CR31","first-page":"641","volume":"59","author":"P Nguyen-Dinh","year":"1981","unstructured":"Nguyen-Dinh P, Hobbs JH, Campbell CC: Assessment of chloroquine sensitivity of Plasmodium falciparum in Choluteca, Honduras. Bull World Health Organ. 1981, 59: 641-646.","journal-title":"Bull World Health Organ"},{"key":"1952_CR32","first-page":"97","volume":"5","author":"JR Mej\u00eda-D\u00edaz","year":"2000","unstructured":"Mej\u00eda-D\u00edaz JR, Alger J, Valenzuela-Castillo R, Jerem\u00edas-Soto R: Evaluate the clinical and parasitological efficacy of chloroquine in the treatment of malaria in children. Hospital Escuela 1998-2000, Tegucigalpa, Honduras. Revista Medica de los Postgrados de Medicina. 2000, 5: 97-104.","journal-title":"Revista Medica de los Postgrados de Medicina"},{"key":"1952_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(00)00201-2","volume":"108","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC: The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasit. 2000, 108: 13-23.","journal-title":"Mol Biochem Parasit"},{"key":"1952_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actatropica.2009.07.008","volume":"114","author":"T Mita","year":"2010","unstructured":"Mita T: Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum. Acta Trop. 2010, 114: 166-170.","journal-title":"Acta Trop"},{"key":"1952_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","volume":"58","author":"T Mita","year":"2009","unstructured":"Mita T, Tanabe K, Kita K: Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int. 2009, 58: 201-209.","journal-title":"Parasitol Int"},{"key":"1952_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.actatropica.2005.04.014","volume":"94","author":"KI Barnes","year":"2005","unstructured":"Barnes KI, White NJ: Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 2005, 94: 230-240.","journal-title":"Acta Trop"},{"key":"1952_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1475-2875-8-159","volume":"8","author":"S Lawpoolsri","year":"2009","unstructured":"Lawpoolsri S, Klein EY, Singhasivanon P, Yimsamran S, Thanyavanich N, Maneeboonyang W, Hungerford LL, Maguire JH, Smith DL: Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J. 2009, 8: 159-","journal-title":"Malar J"},{"key":"1952_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/CMR.00008-09","volume":"22","author":"JK Baird","year":"2009","unstructured":"Baird JK: Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009, 22: 508-534.","journal-title":"Clin Microbiol Rev"},{"key":"1952_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4269\/ajtmh.2009.09-0337","volume":"81","author":"P Orjuela-Sanchez","year":"2009","unstructured":"Orjuela-Sanchez P, da Silva NS, da Silva-Nunes M, Ferreira MU: Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg. 2009, 81: 961-968.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2875-7-35","volume":"7","author":"C Barnadas","year":"2008","unstructured":"Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S, Menard D: Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar J. 2008, 7: 35-","journal-title":"Malar J"},{"key":"1952_CR41","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4269\/ajtmh.2010.10-0259","volume":"83","author":"M Miao","year":"2010","unstructured":"Miao M, Yang Z, Cui L, Ahlum J, Huang Y: Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China. Am J Trop Med Hyg. 2010, 83: 1206-1211.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1590\/S0074-02762009000700012","volume":"104","author":"BE Gama","year":"2009","unstructured":"Gama BE, Oliveira NK, Souza JM, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F: Characterisation of pvmdr1 and pvdhfr genes associated with chemoresistance in Brazilian Plasmodium vivax isolates. Mem Inst Oswaldo Cruz. 2009, 104: 1009-1011.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1952_CR43","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1128\/AAC.00004-09","volume":"53","author":"P Orjuela-Sanchez","year":"2009","unstructured":"Orjuela-Sanchez P, de Santana Filho FS, Machado-Lima A, Chehuan YF, Costa MR, Alecrim MG, del Portillo HA: Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region. Antimicrob Agents Chemother. 2009, 53: 3561-3564.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4269\/ajtmh.2009.81.19","volume":"81","author":"C Barnadas","year":"2009","unstructured":"Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S, Menard D: High prevalence and fixation of Plasmodium vivax dhfr\/dhps mutations related to sulfadoxine\/pyrimethamine resistance in French Guiana. Am J Trop Med Hyg. 2009, 81: 19-22.","journal-title":"Am J Trop Med Hyg"},{"key":"1952_CR45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1128\/AAC.47.5.1514-1521.2003","volume":"47","author":"M Imwong","year":"2003","unstructured":"Imwong M, Pukrittayakamee S, Renia L, Letourneur F, Charlieu JP, Leartsakulpanich U, Looareesuwan S, White NJ, Snounou G: Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother. 2003, 47: 1514-1521.","journal-title":"Antimicrob Agents Chemother"},{"key":"1952_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.actatropica.2005.10.003","volume":"97","author":"S Kaur","year":"2006","unstructured":"Kaur S, Prajapati SK, Kalyanaraman K, Mohmmed A, Joshi H, Chauhan VS: Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. Acta Trop. 2006, 97: 174-180.","journal-title":"Acta Trop"},{"key":"1952_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.exppara.2010.07.011","volume":"127","author":"S Zakeri","year":"2011","unstructured":"Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Kakar Q, Atta H, Djadid ND: Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan. Exp Parasitol. 2011, 127: 167-172.","journal-title":"Exp Parasitol"},{"key":"1952_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2875-8-20","volume":"8","author":"S Zakeri","year":"2009","unstructured":"Zakeri S, Motmaen SR, Afsharpad M, Djadid ND: Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East. Malar J. 2009, 8: 20-","journal-title":"Malar J"},{"key":"1952_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pt.2007.03.002","volume":"23","author":"VN Hawkins","year":"2007","unstructured":"Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH: Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol. 2007, 23: 213-222.","journal-title":"Trends Parasitol"},{"key":"1952_CR50","volume-title":"Situation of management of medicines supply for treatment of malaria in Central America countries. Presented to United States Agency for International Development by the SPS Program","author":"Strengthening Pharmaceutical Program","year":"2008","unstructured":"Strengthening Pharmaceutical Program: Situation of management of medicines supply for treatment of malaria in Central America countries. Presented to United States Agency for International Development by the SPS Program. 2008, Health MSf ed. Arlington, VA"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-10-376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-10-376\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-10-376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:27:34Z","timestamp":1548239254000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-10-376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1952"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-10-376","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"376"}}